Barcelo, Kareen Mae N.
HRN: 12-27-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2023
CEFUROXIME 500MG (TAB)
11/16/2023
11/22/2023
PO
500MG
BID
Thickly Msaf
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes